Thermo Fisher sees FY25 adjusted EPS $23.10-$23.50, consensus $23.18

Sees FY25 revenue $43.5B-$44B, consensus $44.67B. Sees FY25 market growth slightly positive. Sees FY25 net interest expense $250M. Sees FY25 tax rate 11.5%. Sees FY25 capital expenditures $1.4B-$1.7B. Sees FY25 free cash flow $7B-$7.4B. Sees FY25 adjusted operating margin expansion of 90 basis points. Says expects headwind for revenue from foreign exchange of $650M. Comments and guidance taken from Q4 earnings conference call.